3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Surgical Wound Infection
4
Neoplasms
4
Colorectal Neoplasms
3
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Skin Neoplasms
1
Sepsis
1
Pancreatic Fistula
1
Neutropenia
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Intestinal Neoplasms
1
Inflammation
1
Infections
1
Hematologic Neoplasms
1
Glioblastoma
1
Fever
1
Febrile Neutropenia
1
Exanthema
1
Emergencies
1
Duodenal Neoplasms
1
Discitis
1
Interventions
Meropenem
7
Vancomycin
6
Filgrastim
5
Ceftazidime
5
pegylated granulocyte colony-stimulating factor
4
Cefepime
4
pegfilgrastim
3
Levofloxacin
3
Ciprofloxacin
3
Amikacin
3
Teicoplanin
2
Piperacillin, Tazobactam Drug Combination
2
Linezolid
2
Interleukin 1 Receptor Antagonist Protein
2
Amoxicillin-Potassium Clavulanate Combination
2
ceftolozane, tazobactam drug combination
1
Vaccination
1
Therapeutics
1
Tazobactam
1
TKN732
1
Sodium Chloride
1
Simvastatin
1
Positron Emission Tomography Computed Tomography
1
Pneumococcal Vaccines
1
Piperacillin
1
Ofloxacin
1
NF protocol
1
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
1
Micafungin
1
Metronidazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Febrile Neutropenia
×
Anti-Bacterial Agents
×
Clear all
NCT05393505
2022-12-06
FRANCiS-NF
The University of Hong Kong
Phase 4
Unknown
344 enrolled